BHVN

Biohaven Pharmaceutical Holding Company Ltd.

Delisted

BHVN was delisted on the 3rd of October, 2022.

222 hedge funds and large institutions have $5.7B invested in Biohaven Pharmaceutical Holding Company Ltd. in 2021 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 93 increasing their positions, 67 reducing their positions, and 39 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
222
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
14
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$92.9M
Puts
$79.8M
Net Calls
Net Calls Change

Top Buyers

1 +$128M
2 +$89.3M
3 +$88.2M
4
AG
Artal Group
Luxembourg
+$38.8M
5
Wells Fargo
Wells Fargo
California
+$28.7M

Top Sellers

1 -$149M
2 -$97.1M
3 -$48.5M
4
KCM
Kingdon Capital Management
New York
-$44.6M
5
EP
Eversept Partners
New York
-$16.6M
Name Holding Trade Value Shares
Change
Change in
Stake
101
$3.26M
102
$2.97M
103
$2.84M
104
$2.8M
105
$2.67M
106
$2.62M
107
$2.41M
108
$2.33M
109
$2.33M
110
$2.33M
111
$2.33M
112
$2.15M
113
$2.03M
114
$1.99M
115
$1.92M
116
$1.87M
117
$1.61M
118
$1.55M
119
$1.47M
120
$1.42M
121
$1.36M
122
$1.32M
123
$1.29M
124
$1.23M
125
$1.22M